Squarepoint Ops LLC Aptinyx Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.11 - $3.0 $31,681 - $45,045	-15,015 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.21 - $2.89 $42,091 - $55,042	-19,046 Reduced 55.92%	15,015 $35,000
Q2 2021 Aug 16, 2021	SELL	$2.39 - $3.5 $64,331 - $94,209	-26,917 Reduced 44.14%	34,061 $96,000
Q1 2021 May 17, 2021	BUY	$2.86 - $4.33 $131,737 - $199,448	46,062 Added 308.81%	60,978 $183,000
Q4 2020 Feb 16, 2021	SELL	$2.93 - $4.3 $169,116 - $248,191	-57,719 Reduced 79.46%	14,916 $52,000
Q3 2020 Nov 16, 2020	SELL	$3.05 - $4.99 $5,441 - $8,902	-1,784 Reduced 2.4%	72,635 $246,000
Q2 2020 Aug 14, 2020	BUY	$1.99 - $4.4 $79,804 - $176,453	40,103 Added 116.86%	74,419 $310,000
Q1 2020 May 15, 2020	SELL	$1.81 - $5.03 $11,042 - $30,688	-6,101 Reduced 15.1%	34,316 $74,000
Q4 2019 Feb 14, 2020	BUY	$2.84 - $4.25 $114,784 - $171,772	40,417 New	40,417 $138,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.